Hyperbaric Oxygen Therapy: First Human Study Shows Reversal in Biology of Aging



TEL AVIV – November 18, 2020: In a scientifically verified approach, signalling an important breakthrough in the study of aging, Tel Aviv University and The Sagol Center for Hyperbaric Medicine and Research at Shamir Medical Center announced today that, for the first time in humans, two key biological hallmarks of aging, telomere length shortening, and accumulation of senescent cells, can be reversed. The prospective clinical trial, published in peer-reviewed Journal Aging, utilizes Hyperbaric Oxygen Therapy protocols to demonstrate cellular level improvement in healthy aging adults.


Hyperbaric Oxygen Therapy targets aging as a reversible disease.


The prospective clinical trial is part of a comprehensive aging research program taking place in Israel. It was conducted by Prof. Shai Efrati, MD, from the Faculty of Medicine and Sagol School of Neuroscience at Tel Aviv University, and Amir Hadanny, MD, Chief Medical Research Officer of The Sagol Center for Hyperbaric Medicine and Research and co-author of the study. Using a specific protocol of hyperbaric oxygen therapy (HBOT), telomere length was significantly increased and senescent cells were reduced in a population of healthy aging subjects. The study was published in the peer-reviewed journal Aging. Titled: Hyperbaric Oxygen Therapy Increases Telomere Length and Decreases Immunosenescence in Isolated Blood Cells: A Prospective Trial.


A significant breakthrough in the study of aging

The biological deterioration of aging is cited as a major risk factor for cancer, cardiovascular diseases, diabetes, dementia, and Alzheimer’s disease. At the cellular level, two key hallmarks of the aging process are:

  1. The shortening of telomere length of approximately 20-40 bases per year, which is associated with a variety of serious life-threatening illnesses; and

  2. The accumulation of senescent cells, the so-called “old malfunctioning cells,” inhibit cell proliferation. The accumulation of senescence contributes to many age-associated conditions and illnesses, while the elimination of those cells can reverse them, as shown in previous animal studies.


Read the source article here!

14 views
Got a question? Reach out to us.

©2020 SoCal Hyperbaric Oxygen Center

  • RSS Social Icon
  • Yelp Social Icon
  • Instagram Social Icon
  • Facebook Social Icon
  • Twitter Social Icon
  • LinkedIn Social Icon

The information provided is for educational purposes only. It is not intended as a substitute for the diagnosis, treatment, cure, prevention and advice of a qualified licensed professional. This website offers people general information about hyperbaric chamber oxygen therapy (HBOT) in Los Angeles, California, and in no way should anyone consider that this site represents the practice of medicine. This site assumes no responsibility for how this material is used. Also note that this website frequently updates its contents, due to a variety of reasons. Not all statements or implied hyperbaric chamber oxygen treatments on this website have been evaluated or approved by the FDA. It is important that you do not reduce, change, or discontinue any medication or treatment without first consulting your doctor. Please consult with your doctor before beginning any new hyperbaric oxygen therapy program.